sodium salicylate has been researched along with nabumetone in 1 studies
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (nabumetone) | Trials (nabumetone) | Recent Studies (post-2010) (nabumetone) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 393 | 105 | 60 |
| Protein | Taxonomy | sodium salicylate (IC50) | nabumetone (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 5 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.868 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.998 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.868 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, CJ; Cameron, IL; Hardman, WE; Lee, M | 1 |
1 other study(ies) available for sodium salicylate and nabumetone
| Article | Year |
|---|---|
Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats.
Topics: 1,2-Dimethylhydrazine; 16,16-Dimethylprostaglandin E2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Butanones; Carcinogens; Colon; Colonic Neoplasms; Cyclooxygenase Inhibitors; Dimethylhydrazines; Indomethacin; Male; Nabumetone; Rats; Rats, Sprague-Dawley; Sodium Salicylate | 1997 |